Interestingly, several brain conditions, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and traumatic brain injury (TBI), show a significant increase in expression levels of TSPO, reflecting microglial activation that is likely to result in the production of protective neurosteroids, as a homeostatic response [8]. This evidence concerns the gene TSPO and Parkinson disease.